Abstract. Postsynaptic density-95 (PSD-95/SAP-90) is a palmitoylated peripheral membrane protein that scaffolds ion channels at excitatory synapses. To elucidate mechanisms for postsynaptic ion channel clustering, we analyzed the cellular trafficking of PSD-95. We find that PSD-95 transiently associates with a perinuclear membranous compartment and traffics with vesiculotubular structures, which migrate in a microtubule-dependent manner. Trafficking of PSD-95 with these vesiculotubular structures requires dual palmitoylation, which is specified by five consecutive hydrophobic residues at the NH 2 terminus. Mutations that disrupt dual palmitoylation of PSD-95 block both ion channel clustering by PSD-95 and its synaptic targeting. Replacing the palmitoylated NH 2 terminus of PSD-95 with alternative palmitoylation motifs at either the NH 2 or COOH termini restores ion channel clustering also induces postsynaptic targeting, respectively. In brain, we find that PSD-95 occurs not only at PSDs but also in association with intracellular smooth tubular structures in dendrites and spines. These data imply that PSD-95 is an itinerant vesicular protein; initial targeting of PSD-95 to an intracellular membrane compartment may participate in postsynaptic ion channel clustering by PSD-95.
Introduction
Rapid and efficient neurotransmission requires proper synaptic assembly of signal transducing protein networks. At excitatory synapses, glutamate receptors are clustered at the postsynaptic density (PSD) 1 , a thickening of the cytoskeleton beneath the plasma membrane. Also associated with the PSD are cytosolic enzymes including calcium calmodulin-dependent protein kinase II and neuronal nitric oxide synthase that modulate glutamatergic stimuli (Brenman et al., 1996a; Kennedy, 1998) .
Although recent studies have helped to define the composition of the PSD (Kornau et al., 1997; Sheng and Wyszynski, 1997; Craven and Bredt, 1998) , mechanisms for assembling protein complexes at postsynaptic sites are poorly understood. One attractive candidate is the postsynaptic density protein, PSD-95/SAP-90, a membrane-associated guanylate kinase (MAGUK; Cho et al., 1992; Kistner et al., 1993) that employs PDZ motifs to cluster proteins into complexes at synaptic sites (Kim et al., 1995; Kornau et al., 1995; Brenman et al., 1996a) . PSD-95 functions as a molecular scaffold to synaptically anchor Shaker type K ϩ channels, N -methyl-D -aspartate (NMDA) type glutamate receptors, and associated downstream signaling enzymes (Kornau et al., 1997; Sheng and Wyszynski, 1997; Craven and Bredt, 1998) . Genetic analyses have highlighted these roles for MAGUK proteins in synaptic organization and function. Mutations of discs large ( dlg ), a MAGUK of Drosophila , perturb postsynaptic clustering of a Shaker type K ϩ channel at the larval neuromuscular junction (Tejedor et al., 1997) . Furthermore, targeted disruption of PSD-95 in mouse alters NMDA receptor mediated synaptic plasticity (Migaud et al., 1998) .
Because postsynaptic protein clustering critically participates in both synaptogenesis and plasticity, mechanistic understanding of postsynaptic protein trafficking is an important goal. PSD-95 itself is a valuable tool for studying this protein sorting problem because fluorescently tagged PSD-95-GFP fusion proteins are targeted appropriately to the PSD (Arnold and Clapham, 1999; Craven et al., 1999) . Taking advantage of this model, recent work shows that postsynaptic clustering of PSD-95 in hippocampal neurons critically relies on three structural features: the palmitoylated NH 2 terminus, the first and second PDZ domains, and a synaptic targeting motif within the COOH-terminal 25 amino acids (Craven et al., 1999) . How these molecular features of PSD-95 mediate postsynaptic clustering remains unknown.
Some insight into mechanisms for protein sorting in neurons has been gained by comparison with polarized protein targeting in epithelial cells. Many transmembrane proteins that occur along the basolateral surface of epithelial cells have a somatodendritic or postsynaptic distribution in neurons whereas apical proteins of epithelial cells are typically found in neuronal axons (Dotti and Simons, 1990; Jareb and Banker, 1998; Rongo et al., 1998) . Cellular analyses of epithelia have determined that targeting of transmembrane proteins to either the apical or basolateral membrane occurs in sorting endosomal compartments (Trowbridge et al., 1993) . It is unclear whether similar sorting compartments mediate postsynaptic clustering in neurons or whether this type of processing would apply at all to a palmitoylated peripheral membrane protein, like PSD-95.
To clarify mechanisms for postsynaptic sorting and assembly of postsynaptic proteins, we have evaluated subcellular trafficking of fluorescently labeled PSD-95 proteins. Strikingly, we find that PSD-95 is sorted with perinuclear vesicles in both heterologous cells and in developing neurons. When visualized in living cells, PSD-95 positive vesicles migrate to and from perinuclear vesicles and this movement requires intact microtubules. Site-directed mutagenesis demonstrates that perinuclear vesicular sorting and ion channel clustering of PSD-95 in heterologous cells and its postsynaptic targeting in neurons all rely on dual palmitoylation of cysteines 3 and 5, and that the yet unidentified palmitoyltransferase responsible for this modification recognizes a consensus of 5 consecutive hydrophobic amino acids. Replacing the palmitoylated NH 2 terminus of PSD-95 with alternative palmitoylation motifs at either the NH 2 or COOH terminus restores ion channel clustering and postsynaptic targeting. These data imply that PSD-95 is not merely a static cytoskeletal element but that PSD-95 is an itinerant vesicular protein and that initial targeting of PSD-95 to an intracellular membrane compartment may participate in postsynaptic ion channel clustering by PSD-95.
Materials and Methods

Antibodies
The following antibodies were used: rabbit polyclonal antibodies to K v 1.4 (Kim et al., 1995) , PSD-95 (Brenman et al., 1996b) , and NR2B (Zymed) and monoclonal antibodies to PSD-95 (#046; Affinity Bioreagents), NR1 (PharMingen), GFP (Quantum, Clontech), HA epitope tag (BABCO), and FLAG epitope tag (Kodak). Dr. Frances Brodsky (University of California San Francisco) kindly provided rabbit polyclonal antibodies to Golgi 58K (TGN-38), and to the cation-independent mannose-6-phosphate-receptor (CI-M6PR). Monoclonal antibodies to E-cadherin and to the apical marker, gp-135, were gifts from Dr. Keith Mostov (University of California San Francisco).
cDNA Cloning and Mutagenesis
Subcloning of wild-type cysteine mutant forms of PSD-95 as NH 2 -terminal fusions with GFP (PSD-95 GFP, C35S, C3S, and C5S), in pGW1 were previously described (Topinka and Bredt, 1998; Craven et al., 1999) . NH 2 -terminal deletion mutants of PSD-95 were generated by PCR and subcloned into the HindIII and EcoRI of GW1. All of the point mutations at the NH 2 -terminal region of PSD-95 derived from full-length PSD-95-GFP in GW1 as described below. PCR was first used to introduce a silent mutation within the codon encoding amino acid 14 to create a unique KpnI. Oligonucleotides encoding the first 13 amino acids of PSD-95 containing the described point mutations were then subcloned into the HindIII-KpnI sites. GAP-43 GFP full-length and mutant forms were generated by PCR and subcloned into the HindIII and Kpn1 sites in frame and in front of GFP in a GFP/GW1 construct described previously (Craven et al., 1999) . PSD-95 paralemmin COOH terminus fusion protein (PSD-95/Parlm) was generated by inserting the last 12 amino acids of paralemmin (Kutzleb et al., 1998) on the COOH terminus of GFP of the PSD-95:C3,5S construct. Proper introduction of all mutations was verified by DNA sequencing.
Cell Transfection and Metabolic Labeling
COS7, HEK-293 and MDCK cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, penicillin, and streptomycin. PC12 cells used the same media containing 5% fetal bovine serum and 10% horse serum and were differentiated for 3 d after transfection in media containing 50 ng/ml NGF. Cells were transfected using Lipofectamine reagent according to the manufacturer's protocol (Gibco). Stable MDCK cells were generated by cotransfecting a PSD-95 expression construct in a GW1 vector together with pcDNAIII and selecting for stable transformants with 1 mg/ml G418. To form polarized monolayers, MDCK cells were plated on 0.4 mm diameter Transwells™ (Corning Costar) and grown for 2-3 d. For studies of palmitoylation, metabolic labeling of transfected COS7 cells was done as previously described (Topinka and Bredt, 1998) .
Transfection of Primary Neuronal Cultures and Immunofluorescent Labeling
Hippocampal cultures were transfected as previously described (Craven et al., 1999) . In brief, acutely dissociated hippocampal neurons from E18 rats were transfected in suspension by lipid-mediated gene transfer. Cells were then plated at a density of 600 cells/mm 2 on glass coverslips (Fisher) and maintained in Neurobasal media (Gibco) supplemented with B27. Coverslips were removed from culture wells and processed for immunofluorescence or GFP as previously described (Craven et al., 1999) . Images were taken under fluorescence microscopy with a 100 ϫ oil-immersion objective (NA ϭ 1.4) affixed to a Leica upright microscope. Confocal microscopy used a Krypton-Argon laser and a BioRad MRC 1024 equipped with a 63 ϫ 1.4 NA oil-immersion objective. Vertical images were reconstructed from 10 consecutive horizontal sections taken with the motor step size set at 1 m.
Electron Microscopic Immunocytochemistry
Adult rats were fixed by transcardial perfusion with a phosphate-buffered aldehyde mixture, consisting of 4% paraformaldehyde and 3% acrolein or 2.5% glutaraldehyde. Sections were prepared (40 m) and blocked in saline buffered with 0.01 M phosphate (PBS) containing 1% BSA. After an overnight incubation with affinity-purified anti-PSD-95 antibody (1 g/ml), sections were processed for pre-embedding colloidal gold immunolabeling, using 1-nm gold conjugated anti-rabbit IgG as the label. A silver intensification kit (Amersham) was then used to enlarge the 1-nm gold particles to Ͼ 5 nm for light and electron microscopic detection (Chan et al., 1990) . These sections were post-fixed with 1% glutaraldehyde, then with 1% osmium tetroxide, and stained en bloc with 4% uranyl acetate. Sections were dehydrated for infiltration with EMBED 812 resin (EM Sciences) and ultrathin sections (80 nm) were examined without counterstaining. Post-embedding colloidal gold labeling was achieved as described (Aoki et al., 1999b) . The 1-nm gold conjugated anti-rabbit IgG was purchased from Goldmark, and the silver-intensification kit was from Amersham.
Imaging of PSD-95 GFP in Live Cells
posure) every 30 seconds for 30-180 min with excitation at 470/40 nm and emission at 525/50 nm. Imaging was done using a Zeiss Axiovert S100 TV inverted microscope equipped with a C-Apochromat (NA ϭ 1. 
Results
PSD-95 Is Sorted with Perinuclear Vesicles in Heterologous Cells and in Neurons
To define cellular processes that mediate postsynaptic ion channel clustering by PSD-95, we first analyzed the subcellular distribution of exogenous PSD-95 expressed in various cell lines. 12 h after transfection of COS cells, wildtype or tagged versions of PSD-95 occur diffusely throughout the cytoplasm but are also conspicuously concentrated at a perinuclear compartment ( Fig. 1 A, top) . The accumulation of fluorescent PSD-95 at this perinuclear region steadily progresses from 5-8 h after transfection (see time lapse below). To determine whether this transient perinuclear localization of PSD-95 corresponds to a specific organelle, transfected cells were double-stained for PSD-95 and either the mannose-6-phosphate receptor, Golgi 58K, TGN38, or DND-99 (Lysotracker). The perinuclear localization of PSD-95 corresponds to that of the mannose 6-phosphate receptor (M6PR; Fig. 1 , B and C), a wellcharacterized marker of late endosomes (Griffiths et al., 1988) . PSD-95 localization only partially overlaps that of the Golgi markers, Golgi 58K, and TGN38; PSD-95 does not overlap at all with the lysosomal marker DND-99 ( Fig.  1 B and data not shown).
As found in COS cells, PSD-95 expressed in either HEK293 or PC12 cells also coincides with the M6PR positive compartment ( Fig. 1 A, bottom, and data not shown). Furthermore, in developing hippocampal neurons we find that transfected PSD-95 GFP (not shown) and endogenous PSD-95 ( Fig. 2) transiently colocalize with the M6PR during the first 2 d in culture. A similar perinuclear localization is observed for NMDA receptor subunits NR1 and NR2B (Fig. 2) . By contrast, the microtubule-associated protein, MAP2, occurs in developing neurites and is not concentrated in the perinuclear domain. As the neurons mature, PSD-95 becomes less concentrated in this perinuclear domain and begins to accumulate in small clusters along the processes (Fig. 2) .
Accumulation of PSD-95 at the Perinuclear Domain Is Brefeldin A-and Nocodazole-sensitive
To help to determine whether sorting of PSD-95 to the perinuclear domain requires active vesicular trafficking, we treated PSD-95-expressing heterologous cells with BFA. BFA has multiple and diverse effects on vesicular trafficking in cells including disassembly of the Golgi complex (Lippincott-Schwartz et al., 1991) . 2 h after transfection, before PSD-95 accumulates in the perinuclear compartment, treatment with BFA completely prevents the accumulation of PSD-95 ( Fig. 3 A) ; instead PSD-95 protein occurs diffusely throughout the cytoplasm. However, addition of BFA after the perinuclear accumulation of PSD-95 does not alter the localization of PSD-95 or its colocalization with M6PR even after prolonged (8 h) treatment (data not shown). These results indicate that accumulation of PSD-95 depends on trafficking through the secretory pathway, but that the perinuclear vesicular domain that PSD-95 resides in is a compartment distinct from the Golgi complex. In contrast, nocodazole, which depolymerizes microtubules and not only disperses Golgiderived tubules but also endosomes (Cole et al., 1996) , blocks accumulation of PSD-95 at the perinuclear compartment and disperses both PSD-95 and the M6PR to similar vesicular structures within the cell (Fig. 3 A) . These results suggest that PSD-95 accumulates in a perinuclear endosomal compartment rather than in the Golgi complex.
PSD-95 GFP Is Trafficked through Pleomorphic Vesiculotubular Structures
We used video microscopy to monitor the dynamics of PSD-95-GFP trafficking in live COS cells starting 5 h after transfection. During the first hour, vesicles and tubular structures are constantly forming and moving towards the plasma membrane as well as to the perinuclear region (see video 1). 1-3 hours later, accumulation of PSD-95 GFP in the perinuclear region becomes obvious and the accumulated PSD-95 GFP persists for the remainder of the imaging period (videos 1 and 2). Pleomorphic tubular structures, rather than small vesicles, are the primary vehicles for the transport of PSD-95 GFP. Fig. 3 D shows examples of the various vesicular and tubular structures containing PSD-95 GFP observed 6 h after transfection. These structures undergo dynamic shape changes as they move along tracks (possibly microtubules) to the cell periphery and to the perinuclear region. Some of these vesicular structures fuse with the plasma membrane. We also observed that tubular elements containing PSD-95 GFP typically undergo dramatic shape changes during their movement. These transport intermediates often bifurcate and show elastic properties, including extension and retraction during movement. Moving tubules undergo continuous budding, translocation, and fusion with other transport intermediates carrying PSD-95 GFP to the plasma membrane or to the perinuclear region. These properties are similar to the trafficking of Golgi-derived vesicular transport intermediates for transmembrane proteins (Sciaky et al., 1997) . Acute addition of nocodazole completely paralyzes PSD-95 transport intermediates, indicating that their movement requires microtubule-mediated transport (video 3).
PSD-95 Localizes to Intracellular Membranes and to the PSD in Cortical Neurons
To determine whether PSD-95 also associates with membranous intracellular structures of neurons within intact brain, we performed electron microscopic immunocytochemical staining of the rat cerebral cortex, using a well characterized anti-PSD-95 antiserum (Brenman et al., 1996a) and established methods for immunocytochemical staining (Aoki et al., 1999b) . Previous ultrastructural studies of PSD-95 in forebrain have been limited to a few studies focusing on the localization of PSD-95 at PSDs (Hunt et al., 1996; Aoki et al., 1998; Valtschanoff et al., 1999) . Consistent with that work, we have found using the postembedding gold method that labeling for PSD-95 occurs at the PSDs of Ͼ 89% of cortical synapses (Aoki et al., 1999a) . However, we also find, using a silver-intensified gold pre-embedding method (Chan et al., 1990) , that PSD-95 localizes to nonsynaptic sites (Fig. 4 A) and is often found in association with the cytosolic surface of membranous intracellular structures. Fig. 4 B shows an example of PSD-95 immunoreactivity associated with intracellular smooth endoplasmic reticulum in a dendritic shaft of a cortical neuron. In a nearby synaptic spine PSD-95 immunoreactivity is associated with the spine apparatus adjacent to an unlabeled PSD of an asymmetric synapse (Fig. 4 B) .
Vesicular Sorting of PSD-95 Requires a Short NH 2 -terminal Palmitoylated Motif
We next determined the region(s) of PSD-95 sufficient for its association with the perinuclear vesicular domain. We first transfected COS cells with a series of progressively larger deletion constructs encoding PSD-95 fused to GFP. This deletion analysis showed that a construct containing the first nine amino acids of PSD-95 fused to GFP occurs diffusely when expressed in COS cells, whereas constructs containing the first 13, 26, 46, or 64 amino acids all transiently accumulate at the perinuclear domain, just like fulllength PSD-95 (Fig. 3 B) .
To determine whether association of PSD-95 with perinuclear vesicles requires NH 2 -terminal palmitoylation, we evaluated the distribution of palmitoylation-deficient mutants. Mutation of cysteine 3 or 5 of PSD-95 to serine prevents palmitoylation (Topinka and Bredt, 1998) , and these mutations completely disrupt vesicular sorting of PSD-95 in COS cells (Fig. 3 C) . Instead, the palmitoylation-deficient mutants occur diffusely throughout the cells. To determine if a dually palmitoylated motif is sufficient for Mutations of Cys3 and/or 5 to Ser (C3,5S, C3S, C5S) or amino acids 6-9 (IVTT) to TEIN (denoted as IVTT*) disrupt vesicular sorting, whereas mutations of amino acids 2, 8, or 9 to Ala (D2A; T8A and T89A) do not. All mutations of amino acid 4 (L4Y, L4A, L4S, and L4D) dramatically alter sorting to the perinuclear domain, with the more hydrophilic changes being more significant. Mutations of amino acids 6 and 7 to hydrophobic ones maintain normal sorting (I6L, V7L), whereas mutating either Cys3 or Cys5 to Leu only partially maintains the perinuclear distribution (C3L, C5L). (D) An enlarged image shows in greater detail the localization of PSD-95 along vesiculotubular structures that resemble Golgi-derived tubules (arrowheads) and also to a perinuclear region (arrows). Bar, 10 m. vesicular trafficking of PSD-95, we replaced amino acids 1-13 of PSD-95 with the first 12 amino acids of growthassociated protein-43 (GAP-43), another dually palmitoylated motif. Indeed, this chimeric protein (GAP/PSD-95) was efficiently palmitoylated (Fig. 5 D) and trafficked to the same perinuclear compartment as wild-type PSD-95 (Fig. 3 B) .
Palmitoylation of PSD-95 Is Determined by a Hydrophobic Consensus Sequence
To analyze further palmitoylation of PSD-95, we determined the structural requirements for this protein lipidation. As shown in Fig. 5 B, constructs containing at least the first 13 amino acids of PSD-95 are efficiently palmitoylated, whereas a construct containing only the first 9 amino acids is not detectably palmitoylated. These data indicate that the palmitoyltransferase that modifies PSD-95 recognizes a short sequence confined to the NH 2 terminus. This short consensus need not occur at the extreme NH 2 terminus, as insertion of 6 amino acids (VSKSGS) between the starter methionine and the palmitoylated cysteines does not influence the efficacy of palmitoylation (Fig. 5 B) .
We further dissected the sequence requirements within the first 13 amino acids. Mutating amino acids 10-13 partially attenuates palmitoylation efficiency whereas mutating amino acids 6-9 almost completely abolishes palmitoylation (Fig. 5, B and D) . We next generated a series of constructs in which we individually mutated amino acids 2-9 of PSD-95 to alanine and evaluated [ 3 H]palmitate labeling in transfected cells. Changing amino acids 4-Leu, 6-Ile or 7-Val to alanine significantly reduces or eliminates palmitoylation, but mutations of 2-Asp, 8-Thr, or 9-Thr has no effect (Fig. 5 C, and data not shown) . These data indicate that mutations of the hydrophobic amino acids disrupt palmitoylation, whereas mutations of hydrophilic amino acids do not. To investigate this further, we individually mutated amino acids 6-Ile and 7-Val to either serine, a hydrophilic amino acid, or to leucine, a hydrophobic amino acid. Both serine mutants are weakly palmitoylated ( Fig. 5 C) whereas the leucine mutants are robustly palmitoylated (Fig. 5 C) . Mutation of amino acid 4 from leucine to either aspartate or serine also disrupts palmitoylation, whereas mutation to the less hydrophilic amino acid tyrosine partially preserves palmitoylation (Fig. 5 C) .
Previous studies showed that mutating cysteine 3 or 5 to serine completely disrupts palmitoylation (Topinka and Bredt, 1998) . That both Cys → Ser mutants are not palmitoylated might now be explained by a requirement of the palmitoyltransferase for a hydrophobic consensus. This interpretation would predict that mutating cysteine 3 or 5 (which themselves are hydrophobic) to another hydrophobic amino acid would preserve palmitoylation of the remaining cysteine. Indeed, we found that Cys3Leu and Cys5Leu mutants show residual palmitoylation that amount to ‫ف‬ 20 and ‫ف‬ 40% of the wild-type level, respectively (Fig. 5 D) . Taken together, these data imply that palmitoylation of PSD-95 is mediated by a short NH 2 -terminal consensus sequence that critically relies on five consecutive hydrophobic amino acids (Cys-Leu-Cys-IleVal).
To determine whether a similar hydrophobic consensus might determine NH 2 -terminal palmitoylation of other proteins, we evaluated GAP-43, whose site of palmitoylation also contains five consecutive hydrophobic amino acids (Met-Leu-Cys-Cys-Met) (Liu et al., 1993) . As found for PSD-95, palmitoylation of GAP-43 is reduced by mutating a hydrophobic amino acid adjacent to the cysteines (Leu-2) to serine. Furthermore, mutating both Leu-2 and Met-5 of GAP-43 to serine nearly abolishes palmitoylation (Fig. 5 E) . On the other hand, palmitoylation is preserved if Leu-2 and Met-5 are mutated to a hydrophobic amino acid (Ile). Thus, palmitoylation of both PSD-95 and GAP-43 appear to be specified by five consecutive hydrophobic amino acids.
To evaluate further the role of palmitoylation in vesicular sorting of PSD-95, we monitored the trafficking of each NH 2 -terminal mutant of PSD-95 in transfected COS cells. We found that all mutations that dramatically reduce protein palmitoylation (Cys3,5Ser, Cys3Ser, Cys5Ser, Leu4Ser, Leu4Asp, and Ile6Ser, Val7Ser) also block accumulation of PSD-95 at the perinuclear compartment (Fig.  3 C) . Conversely, PSD-95 occurs normally at the perinuclear domain in transfections with mutants that preserve palmitoylation (Asp2Ala, Ile6Leu, Val7Leu, Thr8Ala, and Thr8,9Ala) (Fig. 3 C) . For mutants that have reduced efficiency of palmitoylation (Leu4Tyr, Leu4Ala, Cys3Leu, Cys5Leu, Ile6Ala, Val7Ala, and Val7Ser), the density of PSD-95 at the perinuclear domain decreases but remains apparent above the diffuse level in the cytosol (Fig. 3 C) . We also examined the trafficking of a mutant form of PSD-95, Ile6Ser in live cells. This single amino acid change in PSD-95 dramatically reduces its palmitoylation and prevents its vesicular sorting. Imaging of live cells expressing this point mutant form of PSD-95 fails to show formation of any vesicular structures (video 4). Instead, diffuse cytoplasmic GFP signal is seen throughout the recording period.
Basolateral Sorting of PSD-95 in Polarized Epithelial Cells Requires Dual Palmitoylation
The cellular pathways for dendritic and for postsynaptic sorting of certain neuronal transmembrane proteins share features with protein targeting to the basolateral membrane of polarized epithelial cells (Dotti and Simons, 1990; Jareb and Banker, 1998; Rongo et al., 1998) . To determine whether this parallel also applies to sorting of a palmitoylated postsynaptic protein, we evaluated localization of stably transfected PSD-95 in polarized MDCK cells. Indeed, we found that full-length PSD-95 colocalizes with E-cadherin at the basolateral membrane (Fig. 6 A, left) , but not with the apical marker gp-135 (Fig. 6 A, right) . To determine whether palmitoylation is essential for basolateral membrane sorting, we examined the localization of various mutants. Strikingly, all point mutations of PSD-95 that disrupt palmitoylation (Cys3Leu, Leu4Ala, Leu4Ser, Cys5Leu, and Ile6Ser) also block its lateral membrane sorting (Fig. 6 C) . In contrast, PSD-95 occurs at the lateral membrane in transfections with a mutant that retains its palmitoylation (Ile6Leu).
To determine the domains of PSD-95 that, together with the palmitoylated NH 2 terminus, mediate basolateral localization, two stably transfected MDCK cell lines were Figure 6 . Sorting of PSD-95 to the basolateral membrane of polarized epithelial cells requires protein palmitoylation and PDZ domains. (A) In a horizontal optical section (A, top left pair) stably transfected PSD-95 (green) colocalizes with E-cadherin (CAD, red) along the lateral plasma membranes in polarized MDCK cells. PSD-95 (green) and CAD (red) colocalize along the basolateral membranes in a vertical section (A, bottom left pair). PSD-95 (green) does not occur in an apical horizontal section which is positive for the apical marker gp135 (red). A merged vertical section shows that PSD-95 (green) occurs along the basolateral membranes whereas gp135 (red) is confined to the apical membrane. Cells were investigated by confocal fluorescence microscopy and three-dimensional reconstruction. (B) A stably transfected NH 2 -terminal mutant of PSD-95 containing all three PDZ domains (1-PDZ3) is sorted to the basolateral membrane whereas a construct extending through only the first PDZ domain (1-PDZ1) occurs diffusely in the cytosol. Horizontal optical sections at the level of the tight junctions and reconstructed vertical sections are shown. (C) Distribution of wild-type and mutants forms of PSD-95, including I6L, I6S, C3L, C5L, L4A, and L4S in transiently transfected MDCK cells. All of the PSD-95 mutant forms, except for I6L, are expressed diffusely in these cells. The mutant form I6L, which maintains palmitoylation, colocalizes with the basolateral marker E-cadherin. generated that express increasingly longer NH 2 -terminal constructs of PSD-95. The first line, containing the NH 2 terminus and the first PDZ domain (1-PDZ1) occurs diffusely in the cells whereas the second line, containing the NH 2 terminus and the 3 PDZ domains (1-PDZ3) is polarized to the basolateral surface, just like full-length PSD-95 (Fig. 6 B) . These experiments indicate that basolateral membrane targeting requires not only the palmitoylated NH 2 terminus but also the PDZ domains. On the other hand, the SH3 and guanylate kinase regions are not required. It is important to note that, in sub-confluent cultures, palmitoylated PSD-95 constructs colocalize with M6PR positive vesicles whereas mutants that disrupt palmitoylation are expressed diffusely in nonconfluent MDCK cells (data not shown). Taken together, these data indicate that basolateral membrane targeting of PSD-95 requires both palmitoylation and PDZ domain interactions.
Postsynaptic Targeting of PSD-95 Requires Dual Palmitoylation
To evaluate the role of dual palmitoylation in postsynaptic sorting of PSD-95, we evaluated targeting of a series of NH 2 -terminal mutants in primary hippocampal neurons (at DIV 12). We found that dually palmitoylated constructs (wild-type, Thr8,9Ala, Ile6Leu and Val7Leu) all target appropriately to postsynaptic dendritic clusters (Fig. 7 A). By contrast, all nonpalmitoylated constructs occur diffusely in dendrites of transfected neurons (Cys3Ser, Leu4Ser, and Ile6Ser) . Constructs that show reduced palmitoylation (Leu4Tyr, Leu4Ala, Cys3Leu, Cys5Leu, Ile6Ala, Val7Ala, and Val7Ser) are partially clustered in neurons (Fig. 7 A) . The lack of proper sorting of the Cys3Leu and Cys5Leu constructs, which are singly palmitoylated, suggests that there is a fundamental difference between single and dual palmitoylation and that postsynaptic targeting requires dual palmitoylation. Furthermore, adding the NH 2 -terminal dually palmitoylated motif of GAP-43 or the COOH-terminal prenylated and dually palmitoylated motif of paralemmin to PSD-95(C3,5S) significantly restore postsynaptic targeting. With the GAP-43 motif and the paralemmin motif PSD-95 clusters form in 46 and 81% of neurons, whereas only 22% of cells show clusters without these motifs (Fig. 7 B) .
Ion Channel Clustering by PSD-95 Requires Dual Palmitoylation
Certain aspects of channel clustering by MAGUK proteins can be reproduced in a coclustering experiment in heterologous cells (Kim et al., 1995) . In this assay, cotransfection of PSD-95 with Shaker K ϩ channel Kv1.4 causes a striking redistribution of both proteins to raft-like clusters on the cell surface (Fig. 8 A, top) . We used video microscopy to monitor the dynamics of this cluster formation in live cells transfected with . In cells cotransfected with PSD-95 GFP and Kv1.4, the surface patches appear to derive from dynamic vesiculotubular transport intermediates for PSD-95 that undergo dramatic shape changes and fuse with the plasma (see videos 5-7).
To define the role for dual palmitoylation in ion channel clustering we analyzed a series of PSD-95 mutants. We found that mutants of PSD-95 that disrupt palmitoylation, including L4S, I6S, C3S, and C35S, do not form coclustered membrane patches when coexpressed with Kv1.4 (Fig. 8 A, top and lower right panels and data not shown). In contrast, mutants of PSD-95 that do not disrupt palmitoylation of PSD-95 including I6L and V7L coclustered with Kv1.4 (Fig. 8 A, and data not shown) . Furthermore, the NH 2 -terminal palmitoylated motif of GAP-43 or the COOH-terminal palmitoylated motif of paralemmin can functionally substitute for the PSD-95 NH 2 terminus to mediate ion channel clustering (Fig. 8 B) .
Finally, minimal constructs of PSD-95 were designed to define the absolute requirements for ion channel clustering. Kv1.4 clustering is induced by the expression of a construct containing only the first 26 amino acids of PSD-95 fused to PDZ domains 1 and 2. In addition, a construct containing GAP-43, fused to only PDZ domains 1&2 of PSD-95 is capable of clustering Kv1.4 (Fig. 8 C) . These experiments establish that ion channel clustering by PSD-95 requires (a) dual palmitoylation and (b) an appropriate PDZ domain.
Discussion
This work demonstrates that dual palmitoylation of PSD-95 mediates a transient association with perinuclear vesicles and that this lipid modification is also essential for ion channel clustering and postsynaptic targeting. Dual palmitoylation of PSD-95 is determined by a consensus sequence of five consecutive NH 2 -terminal hydrophobic amino acids that include the two modified cysteines. Importantly, all mutations that disrupt dual palmitoylation block perinuclear trafficking, postsynaptic targeting, and ion channel clustering activity of PSD-95.
Synaptic Targeting and Ion Channel Clustering by PSD-95 Require Dual Palmitoylation
This work emphasizes the central role for NH 2 -terminal palmitoylation in protein sorting by PSD-95. Previous studies noted essential roles for cysteines 3 and 5 in both receptor clustering (Hsueh et al., 1997) and postsynaptic targeting of PSD-95 (Craven et al., 1999) . Although these cysteines were identified as sites of palmitoylation (Topinka and Bredt, 1998), it was unclear how this lipid modification participates in synaptic clustering. Several lines of evidence developed here indicate that palmitoylation may mediate ion channel clustering by initially targeting PSD-95 to the cytosolic surface of intracellular vesicles. First, video microscopy suggests that vesiculotubular structures are transport intermediates for coclustering of PSD-95 and Kv1.4 in heterologous cells. Second, localization of PSD-95 to perinuclear vesicles in heterologous cells and developing neurons requires an NH 2 -terminal consensus that supports dual palmitoylation. Third, those mutations that disrupt sorting of PSD-95 to the perinuclear domain prevent both ion channel clustering in heterologous cells and postsynaptic sorting in neurons. In addition, the palmitoylated NH 2 terminus of PSD-95 can functionally be replaced with other NH 2 -or COOH-terminal palmitoylation motifs to mediate ion channel clustering or postsynaptic targeting. Although these mutagenesis experiments can provide only indirect evidence, they do demonstrate a strict correlation between vesiculotubular trafficking and receptor clustering by PSD-95. Taken together, these results support a role for vesicular trafficking in sorting and clustering of PSD-95 at synaptic sites.
Five Consecutive Hydrophobic Amino Acids Specifies Palmitoylation of PSD-95
Our detailed mutagenesis of the NH 2 terminus of PSD-95 demonstrates that a sequence of five consecutive hydrophobic amino acids (containing the two modified cysteines) is essential for palmitoylation. Conservative mutations of any of these five amino acids (including the cysteines) to other hydrophobic amino acids preserve palmitoylation whereas mutations to a hydrophilic amino acid prevent palmitoylation. Interestingly, palmitoylation of GAP-43 is also specified by five consecutive NH 2 -terminal hydrophobic amino acids that otherwise shares no similarity with the sequence of PSD-95.
Despite the central role for palmitoylation in diverse cellular processes, the identity of the putative palmitoyltransferase enzyme remains mysterious. Our identification of a strict consensus sequence in PSD-95 and GAP-43 for palmitoylation strongly suggests that modifications of these proteins are enzyme-mediated. Similar to what is found for protein kinases, the PAT appears to recognize a short consensus sequence. Because PSD-95 is such a potent substrate for PAT, the NH 2 terminus of PSD-95 may be a useful tool for biochemical characterization and isolation of this important and elusive enzyme.
Comparison of Postsynaptic Clustering with Basolateral Membrane Sorting
That postsynaptic clustering in neurons and basolateral membrane targeting in epithelial cells both require palmitoylation of PSD-95 suggests interesting parallels between these pathways. Previous analyses of trafficking of transmembrane proteins in epithelial cells have identified critical protein and lipid modifications that mediate polarized protein sorting. Basolateral sorting of several transmembrane proteins is determined by short cytoplasmic tyrosine or dileucine based motifs (Trowbridge et al., 1993 ) that interact with clathrin adaptor proteins, consistent with roles for endocytosis, transcytosis and vesicular budding in basolateral protein sorting (Ohno et al., 1995) . Our data imply that vesicular trafficking may play a role in basolateral membrane localization of a palmitoylated protein in polarized epithelial cells. In addition to palmitoylation, PDZ domains are also essential for lateral membrane targeting. This is consistent with recent work showing that PDZ domains of SAP-97 are important for its lateral membrane localization (Wu et al., 1998) . One major difference is that postsynaptic targeting of PSD-95 requires a short COOHterminal sorting motif (Craven et al., 1999 ) that we find is dispensable for basolateral membrane localization.
Implications for Synaptic Plasticity Regulated by MAGUK Proteins
Mice with mutant PSD-95 protein have a dramatic shift in NMDA receptor-dependent plasticity in hippocampus such that long-term depression (LTD) is blocked and long-term potentiation (LTP) is enhanced (Migaud et al., 1998) . These abnormalities in synaptic plasticity presumably explain why the mutant mice are impaired in a spatial learning task. As postsynaptic signaling cascades downstream of NMDA receptors play critical roles in LTP and LTD, it seems likely that PSD-95 plays an essential role in linking NMDA receptors to these pathways.
How PSD-95 assembles these signaling complexes, however, remains uncertain. Previous models, based on the assumption that PSD-95 and other MAGUKs are static elements of the postsynaptic cytoskeleton suggested a passive role for these proteins in simply retaining receptor clusters and associated signaling enzymes at the synapse (Zito et al., 1997) . The trafficking of PSD-95 with vesiculotubular intermediates here suggests an alternative mechanism, inter-action of PSD-95 with the cytosolic tails of receptors residing in intracellular vesicles followed by insertion of these ion channel complexes into the plasma membrane. Such a model for interaction of PSD-95 with ion channels in sorting endosomes provides a mechanism to help explain recent work showing that PSD-95 regulates polarized trafficking of Kv1.4 (Arnold and Clapham, 1999) . Interestingly, recent work suggests that other multi-PDZ domain proteins involved in synaptic organization including the glutamate interacting protein (GRIP) and LIN-10 also associate with post-Golgi vesicles (Rongo et al., 1998; Xia et al., 1999) . This may indicate a common role for PDZ proteins in transport of receptor-containing vesicles. Such a dynamic mechanism would allow for precise and regulated assembly of synaptic transduction machinery.
